Edition:
United Kingdom

Aurinia Pharmaceuticals Inc (AUP.TO)

AUP.TO on Toronto Stock Exchange

8.42CAD
22 Apr 2019
Change (% chg)

$-0.03 (-0.36%)
Prev Close
$8.45
Open
$8.36
Day's High
$8.48
Day's Low
$8.35
Volume
6,079
Avg. Vol
77,008
52-wk High
$10.47
52-wk Low
$6.58

About

Aurinia Pharmaceuticals Inc. is a Canada-based clinical-stage biopharmaceutical company operating in the field of nephrology and autoimmunity. The Company's primary business is the development of a therapeutic drug to treat autoimmune diseases, in particular lupus nephritis (LN). It is focused on the development of its lead... (more)

Overall

Beta: 1.57
Market Cap(Mil.): $775.27
Shares Outstanding(Mil.): 91.39
Dividend: --
Yield (%): --

Financials

  AUP.TO Industry Sector
P/E (TTM): -- 109.48 62.40
EPS (TTM): -1.01 -- --
ROI: -40.04 7.96 11.78
ROE: -46.08 8.11 12.61

Earnings vs. Estimates